Focus On Taste & Nutrition And Specialty Amino Acids Will Strengthen Product Portfolio

Published
17 Mar 25
Updated
14 Aug 25
AnalystConsensusTarget's Fair Value
₩329,500.00
30.2% undervalued intrinsic discount
14 Aug
₩230,000.00
Loading
1Y
-30.5%
7D
-2.5%

Author's Valuation

₩329.5k

30.2% undervalued intrinsic discount

AnalystConsensusTarget Fair Value

Shared on01 May 25
Fair value Decreased 3.72%

Shared on24 Apr 25
Fair value Decreased 2.17%

Shared on17 Apr 25

AnalystConsensusTarget has increased revenue growth from 2.6% to 3.2%.

Shared on09 Apr 25
Fair value Decreased 0.0000057%

AnalystConsensusTarget has decreased revenue growth from 3.3% to 2.6%, decreased profit margin from 3.0% to 2.4% and increased future PE multiple from 9.3x to 11.6x.

Shared on02 Apr 25
Fair value Decreased 0.025%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on26 Mar 25
Fair value Decreased 0.68%

AnalystConsensusTarget has increased profit margin from 2.2% to 3.0% and decreased future PE multiple from 12.5x to 9.2x.

Shared on19 Mar 25
Fair value Increased 3.59%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.